PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-9.23%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-17.32%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
17.79%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
17.79%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
40.61%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
36.36%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
36.36%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-6.67%
Share reduction while ADI is at 0.22%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-6.67%
Reduced diluted shares while ADI is at 0.30%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
7.15%
Dividend growth of 7.15% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-43.00%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-90.98%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-22.52%
Negative 10Y revenue/share CAGR while ADI stands at 163.77%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-30.24%
Negative 5Y CAGR while ADI stands at 47.44%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-18.27%
Negative 3Y CAGR while ADI stands at 37.29%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
23879.66%
10Y OCF/share CAGR above 1.5x ADI's 763.99%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
98.23%
Below 50% of ADI's 247.67%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
-44.59%
Negative 3Y OCF/share CAGR while ADI stands at 269.45%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
26.28%
Below 50% of ADI's 4591.49%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
27.72%
Positive 5Y CAGR while ADI is negative. John Neff might view this as a strong mid-term relative advantage.
-166.64%
Negative 3Y CAGR while ADI is 276.81%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
283.66%
10Y equity/share CAGR at 50-75% of ADI's 445.03%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
154.84%
5Y equity/share CAGR at 50-75% of ADI's 215.94%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
78.94%
3Y equity/share CAGR at 75-90% of ADI's 95.30%. Bill Ackman pushes for margin or operational changes to match the competitor’s pace.
-68.64%
Cut dividends over 10 years while ADI stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
1.81%
Dividend/share CAGR of 1.81% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
1.65%
3Y dividend/share CAGR of 1.65% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-13.03%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-16.82%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-8.73%
Negative asset growth while ADI invests at 0.66%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-2.32%
We have a declining book value while ADI shows 1.98%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.53%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-13.11%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-22.00%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.